tiger accelerator logo square_edited.jpg

Guzip Biomarkers Corporation

Pavilion:
Industry:

About

Guzip Biomarkers Corporation spun out from Taipei Medical University in Aug 7, 2018, carries a vision for clinical applications of novel DNA methylation biomarkers. Guzip is dedicated to improve women’s health with personalized medicine, and the MPap® DNA Methylation Detection Kit as company’s first IVD test is intended to verify the risk of endometrial cancer prior to an invasive endometrial diagnostic procedure (IVP) assuring the necessity of an IVP.


Contact Us

tiger accelerator logo square.png

Our Website:

Email Us:

Follow Us:

734383_in_linked_media_online_social_icon.png
734399_facebook_media_online_social_icon.png
734377_media_online_social_twitter_icon.png